文献速递重症综合管理与镇静镇痛复苏、休克与脓毒症

药物使用与脓毒症的因果关联:一项两样本孟德尔随机化研究

CAUSAL ASSOCIATION BETWEEN MEDICATION USE AND SEPSIS: A TWO-SAMPLE MENDELIAN RANDOMIZATION STUDY.
PubMed 文献 · Shock · 2025-01-01
一句话结论基因预测的利尿剂使用可能增加脓毒症风险(校正混杂后 OR=1.17,95%CI 1.03-1.34,P=0.018),其他药物证据不确定。

本研究采用两样本孟德尔随机化设计,利用全基因组关联研究(GWAS)汇总数据,探讨基因预测的多种药物使用与脓毒症的因果关联。主要分析采用逆方差加权(IVW)、加权中位数、加权众数和MR-Egger回归,敏感性分析包括MR-Egger、MR-PRESSO、Cochran Q和留一法。IVW提示糖尿病药物、利尿剂、甲状腺制剂和肾上腺素能药物可能与脓毒症风险升高相关。去除混杂因素后,仅利尿剂使用与脓毒症风险升高相关(OR=1.17,95%CI 1.03-1.34,P=0.018),其余药物无统计学显著关联。作者结论认为既往使用利尿剂可能增加脓毒症风险,其他药物证据不确定。

要点

  • 基因预测的利尿剂使用与脓毒症风险升高相关(OR=1.17,95%CI 1.03-1.34,P=0.018),为去除混杂因素后的IVW结果。
  • 未校正混杂时,糖尿病药物(OR=1.08,95%CI 1.02-1.15,P=0.015)、利尿剂(OR=1.08,95%CI 1.01-1.15,P=0.034)、甲状腺制剂(OR=1.08,95%CI 1.03-1.13,P=0.001)和肾上腺素能药物(OR=1.09,95%CI 1.01-1.18,P=0.037)均与脓毒症风险升高相关。
  • 去除混杂因素后,糖尿病药物、甲状腺制剂和吸入性肾上腺素能药物与脓毒症无统计学显著关联。
  • 糖尿病药物、抗血栓药、肾素-血管紧张素系统药物、苯胺类和糖皮质激素的数据集可能存在异质性;去除混杂后未观察到异质性。
  • MR-Egger回归提示除抗血栓药与脓毒症的关联外,水平多效性对所有关联影响很小;MR-PRESSO未发现离群值;留一法分析证实关联不由任何单一因素驱动。

适用人群与场景

  • 基于GWAS汇总数据的人群,涉及选定的药物使用与脓毒症;具体纳入和排除人群原文未描述。

研究设计与关键结果

  • 研究设计为两样本孟德尔随机化研究,利用选定的药物使用与脓毒症的全基因组关联研究(GWAS)汇总数据;分析采用逆方差加权(IVW)、加权中位数、加权众数和MR-Egger回归方法,敏感性分析包括MR-Egger、MR-PRESSO、Cochran Q和留一法。
  • IVW方法提示基因预测的糖尿病药物使用(OR=1.08,95%CI 1.02-1.15,P=0.015)、利尿剂(OR=1.08,95%CI 1.01-1.15,P=0.034)、甲状腺制剂(OR=1.08,95%CI 1.03-1.13,P=0.001)和肾上腺素能药物(OR=1.09,95%CI 1.01-1.18,P=0.037)可能与脓毒症风险升高相关。
  • 糖尿病药物、抗血栓药、肾素-血管紧张素系统药物、苯胺类和糖皮质激素的数据集可能存在异质性。
  • MR-Egger回归结果提示除抗血栓药与脓毒症的关联外,水平多效性对所有关联影响很小;MR-PRESSO检验未发现离群值;留一法分析证实关联不由任何单一因素驱动。
  • 去除混杂因素后,IVW方法提示基因预测的利尿剂使用(OR=1.17,95%CI 1.03-1.34,P=0.018)可能与脓毒症风险升高相关,而糖尿病药物、甲状腺制剂和吸入性肾上腺素能药物则无统计学显著关联;未观察到异质性;MR-Egger回归提示水平多效性对所有关联影响很小;MR-PRESSO检验未发现离群值;留一法分析证实关联不由任何单一因素驱动。

证据类型、等级与局限

  • 证据类型:两样本孟德尔随机化研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者结论认为既往使用利尿剂可能增加脓毒症风险,其他药物的证据不确定。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Objective: This study aimed to explore the causal association between genetically predicted medication use and sepsis. Methods: Utilizing summary data from genome-wide association studies (GWAS) on selected medications use and sepsis, a two-sample Mendelian randomization (MR) design was employed. Analysis was conducted using the Inverse Variance Weighted (IVW), weighted median, weighted mode, and MR-Egger regression methods. Sensitivity analysis included MR-Egger, MR-PRESSO, Cochran's Q, and leave-one-out methods. Results: The IVW method suggested that genetically predicted medication use, including Drugs used in diabetes (OR = 1.08, 95%CI: 1.02-1.15, P = 0.015), diuretics (OR = 1.08, 95%CI: 1.01-1.15, P = 0.034), thyroid preparations (OR = 1.08, 95%CI: 1.03-1.13, P = 0.001), and adrenergics (OR = 1.09, 95%CI: 1.01-1.18, P = 0.037), might be causally associated with a higher risk of sepsis. Datasets for drugs in diabetes, antithrombotic agents, renin-angiotensin system agents, anilides, and glucocorticoids may exhibit heterogeneity. MR-Egger regression results indicated minimal influence of horizontal pleiotropy on all associations except possibly for antithrombotic agents and sepsis. MR-PRESSO test found no outliers. Leave-one-out analysis confirmed associations were not driven by any single factor. After removing confounders, the IVW method suggested that genetically predicted diuretics use (OR = 1.17, 95%CI: 1.03-1.34, P = 0.018) might be causally associated with a higher risk of sepsis, while drugs used in diabetes, thyroid preparations, and inhaled adrenergics were not. No heterogeneity was observed. MR-Egger regression results indicated the minimal influence of horizontal pleiotropy on all associations. MR-PRESSO test found no outliers. Leave-one-out analysis confirmed any single factor did not drive associations. Conclusions: This study found that prior use of diuretics may increase sepsis risk, with inconclusive evidence for other medications.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Sun M, Chen Y, Jin Z, et al. CAUSAL ASSOCIATION BETWEEN MEDICATION USE AND SEPSIS: A TWO-SAMPLE MENDELIAN RANDOMIZATION STUDY. Shock. 2025. PMID: 40101982. doi:10.1097/SHK.0000000000002582

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。